ECSP003541A - COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES - Google Patents
COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINESInfo
- Publication number
- ECSP003541A ECSP003541A ECSP003541A ECSP003541A EC SP003541 A ECSP003541 A EC SP003541A EC SP003541 A ECSP003541 A EC SP003541A EC SP003541 A ECSP003541 A EC SP003541A
- Authority
- EC
- Ecuador
- Prior art keywords
- combination
- inhibitors
- coa reductase
- medicines
- hmg coa
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere al uso de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.The invention relates to the use of a combination of at least one selected MTP inhibitor (component A) and an HMg-CoA reductase inhibitor (component B) for the fight against diseases of the cardiovascular system, to medicines containing this combination and to their obtaining.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003541 ECSP003541A (en) | 2000-06-23 | 2000-06-23 | COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003541 ECSP003541A (en) | 2000-06-23 | 2000-06-23 | COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003541A true ECSP003541A (en) | 2000-10-24 |
Family
ID=42041159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003541 ECSP003541A (en) | 2000-06-23 | 2000-06-23 | COMBINATION OF MTP INHIBITORS AND HMG COA REDUCTASE INHIBITORS AND THEIR USE IN MEDICINES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003541A (en) |
-
2000
- 2000-06-23 EC ECSP003541 patent/ECSP003541A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8577901A1 (en) | PHARMACEUTICAL FORMULATION | |
| EE04990B1 (en) | Pharmaceutical compositions containing an HMG reductase inhibitor, their use and method of preparation | |
| CL2017001847A1 (en) | A solid pharmaceutical dosage formulation | |
| BRPI0413363A (en) | dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors | |
| BR0317715A (en) | Compositions and processes of use of collajolie | |
| DOP2000000022A (en) | COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES. | |
| PA8523901A1 (en) | PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE ESTER CHOLESTERILE TRANSFER PROTEIN | |
| PA8564901A1 (en) | PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE CHOLESTERILE ESTERES TRANSFER PROTEIN | |
| PA8513601A1 (en) | PHARMACEUTICAL COMPOSITIONS OF GLUCOGENOPHOSPHORILASE INHIBITORS | |
| DK1373259T3 (en) | Pyridazinonal dose reductase inhibitors | |
| HN2003000227A (en) | KINASE INHIBITORS | |
| HN2001000146A (en) | PIRAZOL DERIVATIVES | |
| CO5550464A2 (en) | COMBINATION OF AN ALDOSTERONE RECEIVER AGONIST WITH AN HMG INHIBITOR | |
| BRPI0410555A (en) | solid preparation | |
| CY1108725T1 (en) | Combination of NMDA antagonist and acetylcholinesterase inhibitors for the treatment of ALZHEIMER | |
| BRPI0413468A (en) | pyrrol-based hmg-coa reductase inhibitors | |
| ES2161548T3 (en) | COMBINATION OF AN INHIBITOR OF ALDOSA REDUCTASA AND AN INHIBITOR OF GLUCOGENO FOSFORILASA. | |
| CR8824A (en) | DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
| BRPI0507652A (en) | pharmaceutical compositions comprising a benzoidiazepine derivative and an rsv fusion protein inhibitor | |
| BRPI0507654A (en) | pharmaceutical composition comprising a benzodiazepine derivative and an rsv fusion protein inhibitor | |
| CY1110906T1 (en) | PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL | |
| WO2003057205A3 (en) | Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs | |
| CR9521A (en) | NEW METHOD OF TREATMENT OF HYPERLIPEDEMIA | |
| DK0991424T3 (en) | Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor | |
| BRPI0417138A (en) | n-alkyl pyrroles as hmg coa reductase inhibitors |